ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Augustus raised $180 million in Series B funding, reaching a $1 billion valuation. The round brings the company's total funding to $240 million. The investment will support expansion of its AI-powered platform for clinical trial management.
Tap to vote and see what everyone thinks.
Summary by ByteBrief